These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1697373)

  • 1. Vascular pressor responses in treated and untreated essential hypertension.
    Donnelly R; Elliott HL; Howie CA; Sumner DJ; Reid JL
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):191-6. PubMed ID: 1697373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of nifedipine and doxazosin in essential hypertension.
    Donnelly R; Elliott HL; Meredith PA; Howie CA; Reid JL
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):479-86. PubMed ID: 1380588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in serum total angiotensin-converting enzyme activity with enalapril therapy in humans: a controlled trial.
    Stokes GS; Monaghan JC; Marwood JF; Okoro EO; Johnston H
    Clin Exp Pharmacol Physiol; 1992 May; 19(5):297-9. PubMed ID: 1325880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-effect relationships and individual responses to doxazosin in essential hypertension.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1989 Nov; 28(5):517-26. PubMed ID: 2531605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressor responsiveness in essential hypertension and the effects of treatment with an alpha blocker, calcium antagonist or ACE inhibitor.
    Reid JL; Donnelly R; Meredith PA; Elliott HL
    Clin Exp Hypertens A; 1989; 11 Suppl 1():247-56. PubMed ID: 2568200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
    Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
    Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic ketanserin in essential hypertension: antihypertensive mechanisms and pharmacokinetics.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1987 Nov; 24(5):599-606. PubMed ID: 3325090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
    J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
    Lantelme P; Lo M; Sassard J
    Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension.
    Taylor SH; Lee PS; Sharma SK
    Am Heart J; 1988 Dec; 116(6 Pt 2):1820-5. PubMed ID: 2904757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium and blood pressure regulation in normal and hypertensive subjects.
    Bianchetti MG; Beretta-Piccoli C; Weidmann P; Link L; Boehringer K; Ferrier C; Morton JJ
    Hypertension; 1983; 5(4 Pt 2):II57-65. PubMed ID: 6345376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative effects of doxazosin and enalapril in patients with arterial hypertension and exercise-induced acute myocardial ischemia].
    Passarelli P; Galiè N; Limonetti P; Branzi A; Magnani B
    Cardiologia; 1991 Oct; 36(10):777-83. PubMed ID: 1686851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects and pharmacokinetics of single and consecutive administration of doxazosin in patients with mild to moderate essential hypertension.
    Shionoiri H; Yasuda G; Yoshimura H; Umemura S; Miyajima E; Miyakawa T; Takagi N; Kaneko Y
    J Cardiovasc Pharmacol; 1987 Jul; 10(1):90-5. PubMed ID: 2441160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy.
    Englert RG; Mauersberger H
    Am Heart J; 1988 Dec; 116(6 Pt 2):1826-32. PubMed ID: 2904758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients.
    Zou D; Grote L; Eder DN; Radlinski J; Hedner J
    Sleep Med; 2010 Mar; 11(3):325-8. PubMed ID: 20171140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of angiotensin II, losartan, and enalapril on baroreflex control of heart rate in conscious rabbits.
    Weinstock M; Gorodetsky E
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):501-7. PubMed ID: 7769820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
    Bunting MW; Widdop RE
    Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response clarification in early drug development.
    Meredith PA; Elliott HL; Donnelly R; Reid JL
    J Hypertens Suppl; 1991 Dec; 9(6):S356-7. PubMed ID: 1840197
    [No Abstract]   [Full Text] [Related]  

  • 19. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II.
    Matsukawa S; Reid IA
    Circ Res; 1990 Dec; 67(6):1462-73. PubMed ID: 2245506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.